Latest News


Older age and diabetes mellitus identified as risk factors for poor...

Different risk factors affect patency between vascular access construction and the first percutaneous transluminal angioplasty, Mahoko Yoshida (Hiroshima University Hospital, Hiroshima, Japan) and colleagues...



Combination of immuno-oncology and liver-directed therapy: Where do we stand?

Ushering in “the era of IO”, Brad Wood calls for interventional oncologists to learn the language of immuno-oncology—“the other IO”—in order to improve care...

Dialysis access needs to be a priority in the COVID-19 era

Panagiotis M Kitrou and Nicholas Inston discuss the impact of the COVID-19 pandemic on vascular access services. Despite the disruption caused, they are optimistic...


NOTE: This video is ONLY available to watch in selected countries and geographies Ripal Gandhi (Miami, USA) outlines his initial experiences with the Caterpillar™ Arterial Embolization Device (BD), a product, which he says is easy to utilize, shows good trackability in tortuous vessels and allows for “very accurate placement”. Gandhi describes the novel device, which consists...
Matthew Callstrom

Matthew Callstrom


Bill Rilling

Matthew Johnson